Dennis Reilly - 19 Jan 2022 Form 4 Insider Report for AGILE THERAPEUTICS INC

Reporting relationship: Chief Financial Officer
Issuer ticker: N/A
Reported as of: 19 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jan 2022, 20:34:04 UTC
Prior SEC filing: 14 Oct 2021
Source filing: View source filing
Reporting owner signature: /s/ Dennis Reilly

Filing notes and source

Key filing fact

Dennis Reilly filed Form 4 for AGILE THERAPEUTICS INC on 20 Jan 2022.

Key facts

This page summarizes Dennis Reilly's Form 4 filing for AGILE THERAPEUTICS INC.
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Jan 2022, 20:34.

Change

Previous filing in this sequence was filed on 14 Oct 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGRX transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +275,000
Change %
Price: $0.000000
Shares after: 275,000
Date: 19 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 275,000
Exercise price: $0.3420
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option was granted on January 19, 2022. 25% of the shares subject to the stock option vest on January 19, 2023, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on January 19, 2026.